Article Topic
A Colorado Woman Was Seriously Ill. No One Suspected Her Imported Drugs.
In this February 4th, 2019 editorial for Colorado Politics, Denver resident Ali Schroer warns, “I experienced firsthand the dangers of counterfeit, imported drugs, and was critically ill for months as we sought to uncover the source of my illness.”
[...]Partnership For Safe Medicines 2019 Congressional Briefings
On Thursday, January 31, 2019, victims of counterfeit medicines and their families, local law enforcement, former DEA agents, and other experts in the fight against counterfeit medicines met for a discussion about the widespread impact fake drugs are having on communities and on the enormous burden the problem places on regulators who are responsible for our drug safety.
Learn more and watch the briefing here.
[...]Former FBI Director Louis Freeh Updates His 2017 Report on the Threat of Congressional Drug Importation Proposals
Former FBI Director Louis Freeh has released an addendum to his 2017 Report on the Potential Impact of Drug Importation Proposals on U.S. Law Enforcement, concluding:
…the government has not done enough to evaluate and improve the capacity of law enforcement to deal with a new pipeline of drugs into the U.S. drug supply, all while . . . more illegal drugs are being shipped to the United States. Passing any drug importation scheme would erase the little progress we have made and set law enforcement further back on their heels.
[...]Importation is “extremely dangerous idea,” says former FBI Director Freeh
In this editorial, which first appeared in The Washington Times on January 29, 2019, former FBI Director Louis J. Freeh revisits the problem drug importation poses to law enforcement and regulatory systems already overburdened by the opioid crisis.
[...]National Association of Manufacturers Exec warns, “Importation Proposals Disguise Serious Risks”
In this January 30, 2019 editorial, which was published in the National Association of Manufacturer’s Shopfloor blog, Vice President of Infrastructure Robyn Boerstling warns that even though legislators have good intentions, importation could “result in disastrous outcomes.”
[...]Police Arrest Bridgewater, Massachusetts Man A Second Time For Selling Fake Pills Made with Fentanyl
For the second time in less than a year, police arrested John Bagley of Bridgewater, Massachusetts. He allegedly sold counterfeit pills made with fentanyl both times…
[...]Oregon Man Purchased 86,000 Counterfeit Oxycodone Pills Laced With Fentanyl
A case brought against an Oregon resident by the U.S. Department of Justice reached its conclusion. Jared Gillespie will spend 97 months in federal prison after pleading guilty to five counts. He purchased tens of thousands of counterfeit oxycodone pills online to sell in his home state…
[...]Woman Arrested By Police In Grand Junction, Colorado Was In Possession Of Fake Pills Made of Fentanyl
While arresting a Grand Junction, Colorado woman on an outstanding warrant, a police K-9 indicated the presence of narcotics in her vehicle. Inside Marie Matos’s car, police discovered two bags filled with hundreds of pills whose markings indicate that they should be oxycodone. However, “based on training, experience and knowledge of this case these are fentanyl pills”…
[...]Importation Is Too Risky, Warns Former FDA Associate Commissioner
In a January 23, 2019 editorial published in The Hill Peter Pitts, a former FDA associate commissioner and the president of the Center for Medicine in the Public Interest, explains why the safety risks of importation far outweigh any savings.
[...]FDA Alert: UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
The impurity detected in the active ingredient for Losartan is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per international Agency for Research on Cancer (IARC) classification. Torrent is only recalling lots of losartan containing products that contain Nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA.
[...]